公司资料
Centogene 股价、新闻与催化剂
- 股票代码:
- CNTG
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- Germany and has traded publicly in the U
股价为何变动
Current closing-price context is not available for CNTG.
公司概览
业务概览
Centogene is a precision medicine and rare-disease diagnostics company that combines testing, data, and patient identification. Its business sits at the intersection of diagnostics, genetics, and rare-disease discovery.
所在地与行业分类
Centogene is headquartered in Germany and has traded publicly in the U.S. market, giving it a global diagnostics profile. It is more of a rare-disease information company than a therapeutics developer.
商业模式特征
The model depends on test utilization, data services, and partnerships with life-science customers and physicians. Investors usually focus on diagnostic demand, international reach, and whether the company can turn rare-disease insight into recurring revenue.
生物医药行业定位
Centogene occupies a diagnostics-and-data niche inside the broader biotech ecosystem. It is not a drug stock, but it is relevant because rare-disease identification and genomic testing support the development pathway.
未来催化剂
- Centogene’s catalysts are rare-disease diagnostics demand and any commercial or strategic update that clarifies the company’s future. The business is still about whether the platform can find a durable footprint.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。